149 related articles for article (PubMed ID: 35973797)
1. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence.
Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P
Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
[TBL] [Abstract][Full Text] [Related]
3. Association between Individual versus Community-level Social Vulnerability and Neonatal Opioid Withdrawal Syndrome among Pregnant Individuals Receiving Buprenorphine for Opioid Use Disorder.
Mason I; Abdelwahab M; Stiles A; Wu J; Venkatesh KK; Rood KM
Am J Perinatol; 2024 May; 41(S 01):e3157-e3163. PubMed ID: 37890511
[TBL] [Abstract][Full Text] [Related]
4. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure.
Pourcyrous M; Elabiad MT; Rana D; Gaston KP; DeBaer L; Dhanireddy R
Pediatr Res; 2021 Aug; 90(2):459-463. PubMed ID: 33214673
[TBL] [Abstract][Full Text] [Related]
6. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality.
Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA
JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
8. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
[TBL] [Abstract][Full Text] [Related]
9. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
[No Abstract] [Full Text] [Related]
10. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
[TBL] [Abstract][Full Text] [Related]
11. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
[TBL] [Abstract][Full Text] [Related]
12. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
13. Infant Mortality Associated With Prenatal Opioid Exposure.
Leyenaar JK; Schaefer AP; Wasserman JR; Moen EL; O'Malley AJ; Goodman DC
JAMA Pediatr; 2021 Jul; 175(7):706-714. PubMed ID: 33843963
[TBL] [Abstract][Full Text] [Related]
14. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
[No Abstract] [Full Text] [Related]
15. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
Isaac L; van den Hoogen NJ; Habib S; Trang T
J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
[TBL] [Abstract][Full Text] [Related]
16. Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome.
Townsel C; Covault JM; Hussain N; Oncken C; Nold C; Campbell WA
J Matern Fetal Neonatal Med; 2021 Mar; 34(5):670-676. PubMed ID: 31092079
[No Abstract] [Full Text] [Related]
17. Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome.
Shrestha S; Roberts MH; Maxwell JR; Leeman LM; Bakhireva LN
Neurotoxicol Teratol; 2021; 86():106975. PubMed ID: 33766722
[TBL] [Abstract][Full Text] [Related]
18. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
Gersch H; Shah D; Chroust A; Bailey B
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
[TBL] [Abstract][Full Text] [Related]
19. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018.
Mallinson DC; Kuo HD; Kirby RS; Wang Y; Berger LM; Ehrenthal DB
Prev Med; 2024 Apr; 181():107914. PubMed ID: 38408650
[TBL] [Abstract][Full Text] [Related]
20. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
